Commitments (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Operating Right-of-Use Assets and Operating Lease Liabilities

The Company has various operating leases for office space and vehicles that expire through 2030. Below is a summary of the Company’s operating right-of-use assets and operating lease liabilities as of March 31, 2026 and December 31, 2025:

	March 31, 2026		December 31, 2025
Operating right-of-use assets	$	684	$	750

Operating lease liabilities, current		268		285
Operating lease liabilities long-term		493		540
Total operating lease liabilities	$	761	$	825

Schedule of Right-of-Use Assets Over the Remaining Lease

Lease payments for the Company’s right-of-use assets over the remaining lease periods as of March 31, 2026 and December 31, 2025 are as follows:

	March 31, 2026			December 31, 2025
2026		248			332
2027		193			192
2028		165			163
2029		158			157
2030		105			104
Total undiscounted lease payments		869			948
Less: Interest*		(108	)		(123	)
Present value of lease liabilities	$	761		$	825

*	Future lease payments were discounted by 3%-7% interest rate.

ORAMED PHARMACEUTICALS INC. 10-Q